211 results on '"Baqi, Younis"'
Search Results
2. Synthesis, pharmacological evaluation, and in silico study of new 3-furan-1-thiophene-based chalcones as antibacterial and anticancer agents
Catalog
Books, media, physical & digital resources
3. Anthraquinone Dyes: A Synthetic and Chemical Characterization Protocol for an Industrial Chemistry Laboratory Course
4. Electron transfer from a new chalcone dye to TiO2 nanoparticles: Synthesis, photophysics, and excited-state dynamics
5. Microwave-Assisted Synthesis of Near-Infrared Chalcone Dyes: a Systematic Approach.
6. Steady-state spectroscopy and ultrafast dynamics of flavylium derivatives in the red spectral region
7. Ligand binding and activation of UTP-activated G protein-coupled P2Y2 and P2Y4 receptors elucidated by mutagenesis, pharmacological and computational studies
8. Antifibrotic and tumor microenvironment modulating effect of date palm fruit (Phoenix dactylifera L.) extracts in pancreatic cancer
9. Age-related shift in LTD is dependent on neuronal adenosine A2A receptors interplay with mGluR5 and NMDA receptors
10. Memory deficits induced by chronic cannabinoid exposure are prevented by adenosine A2AR receptor antagonism
11. Antithrombotic P2Y12 receptor antagonists: recent developments in drug discovery
12. Modulating P1 Adenosine Receptors in Disease Progression of SOD1G93A Mutant Mice
13. A novel P2X2‐dependent purinergic mechanism of enteric gliosis in intestinal inflammation
14. Chronic and acute adenosine A2A receptor blockade prevents long-term episodic memory disruption caused by acute cannabinoid CB1 receptor activation
15. Enhanced intramolecular charge transfer and near-infrared fluorescence in 4-dimethylamino-chalcone analogues through extended conjugation: synthesis, photophysical properties, and theoretical modelling.
16. Anthraquinones as a privileged scaffold in drug discovery targeting nucleotide-binding proteins
17. Inhibitors for the bacterial ectonucleotidase Lp1NTPDase from Legionella pneumophila
18. Ullmann reactions of 1-amino-4-bromoanthraquinones bearing various 2-substituents furnishing novel dyes
19. Induction of oral tremor in mice by the acetylcholinesterase inhibitor galantamine: Reversal with adenosine A2A antagonism
20. Design, Synthesis, Antimicrobial Properties, and Molecular Docking of Novel Furan-Derived Chalcones and Their 3,5-Diaryl-∆ 2 -pyrazoline Derivatives.
21. Caffeine acts through neuronal adenosine A 2A receptors to prevent mood and memory dysfunction triggered by chronic stress
22. Central P2Y12 receptor blockade alleviates inflammatory and neuropathic pain and cytokine production in rodents
23. Impact of in vivo chronic blockade of adenosine A2A receptors on the BDNF-mediated facilitation of LTP
24. Crystal structure of NTPDase2 in complex with the sulfoanthraquinone inhibitor PSB-071
25. l-DOPA disrupts adenosine A2A–cannabinoid CB1–dopamine D2 receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: Biochemical and behavioral studies
26. Effort-related motivational effects of the pro-inflammatory cytokine interleukin-6: pharmacological and neurochemical characterization
27. Conditional neural knockout of the adenosine A2A receptor and pharmacological A2A antagonism reduce pilocarpine-induced tremulous jaw movements: Studies with a mouse model of parkinsonian tremor
28. Isolation and Identification of Phytocompounds from Maytenus dhofarensis and Their Biological Potentials.
29. Modeling ligand recognition at the P2Y12 receptor in light of X-ray structural information
30. The novel adenosine A2A antagonist prodrug MSX-4 is effective in animal models related to motivational and motor functions
31. The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion
32. Allosteric modulators of rhodopsin-like G protein-coupled receptors: Opportunities in drug development
33. Oral tremor induced by galantamine in rats: A model of the parkinsonian side effects of cholinomimetics used to treat Alzheimer's disease
34. Cardiac myocyte-secreted cAMP exerts paracrine action via adenosine receptor activation
35. Dual target strategy: combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates l-DOPA-induced rotational behavior in a rodent model of Parkinsonʼs disease
36. Effort-related motivational effects of the pro-inflammatory cytokine interleukin 1-beta: studies with the concurrent fixed ratio 5/ chow feeding choice task
37. Stimulant effects of adenosine antagonists on operant behavior: differential actions of selective A2A and A1 antagonists
38. Neuroprotective Potential of Adenosine A2A and Cannabinoid CB1 Receptor Antagonists in an Animal Model of Parkinson Disease
39. Structure-activity relationships of anthraquinone derivatives derived from bromaminic acid as inhibitors of ectonucleoside triphosphate diphosphohydrolases (E-NTPDases)
40. Metal-Assisted Oxidative Cyclization of Arylamidrazones I. Synthesis of 3-Acetyl-1,4-dihydro-1-phenyl-1,2,4-benzotriazine
41. Treatment with A2A receptor antagonist KW6002 and caffeine intake regulate microglia reactivity and protect retina against transient ischemic damage
42. Deep brain stimulation of the subthalamic nucleus reverses oral tremor in pharmacological models of parkinsonism: interaction with the effects of adenosine A2A antagonism
43. Synthesis and Antimicrobial Activity of New Benzimidazole derivatives Bearing Five-Membered Heterocyclic Moieties.
44. New Benzimidazoles Bearin 2-Pyrazoline Moiety: Synthesis and Antimicrobial Activity.
45. Synthesis and structure-activity relationships of cerebroside analogues as substrates of cerebroside sulphotransferase and discovery of a competitive inhibitor.
46. Development of Anthraquinone Derivatives as Ectonucleoside Triphosphate Diphosphohydrolase (NTPDase) Inhibitors With Selectivity for NTPDase2 and NTPDase3.
47. Catalyst-free microwave-assisted amination of 2-chloro-5-nitrobenzoic acid
48. Modulating P1 Adenosine Receptors in Disease Progression of SOD1G93A Mutant Mice.
49. A2B Adenosine Receptor Antagonists with Picomolar Potency.
50. 3-(2-Carboxyethyl)indole-2-carboxylic Acid Derivatives: Structural Requirements and Properties of Potent Agonists of the Orphan G Protein-Coupled Receptor GPR17.
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.